Alan Crandall, MD, to Receive Inaugural Chang Humanitarian Award

January 5, 2018: By Jon Swedien
Alan Crandall, MD

Alan Crandall, MD

The American Society of Cataract and Refractive Surgery (ASCRS) Foundation has named Alan Crandall, MD, as the winner of the inaugural Chang Humanitarian Award, the organization announced Dec. 22.

The annual award—endowed by David F. Chang, MD, and his wife, Victoria—was created to highlight outstanding humanitarian work in cataract blindness, the ASCRS said.

Crandall, of the John A. Moran Eye Center at the University of Utah, has exemplified those qualities in his extensive humanitarian work in the US and abroad, the organization said. Locations where Crandall has donated his time and skills include Ghana, Ethiopia, South Sudan, Tanzania, Kenya, Nepal, India, China, Guatemala, Egypt, Micronesia, Tonga, Rwanda, Haiti, and Cuba.

He was one of 66 nominees for the inaugural award.

Crandall will receive the award in April at the 2018 ASCRS meeting in Washington, DC.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility

Coming soon

2018 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales